Paracetamol infusion-related severe hypotension and cardiac arrest in a child

Ayhan Yaman1, Baver Demir2, Fatma Burcu Belen3

  • 1Pediatric Intensive Care Unit, Gaziantep Children's Hospital, Gaziantep, Turkey.

Insights

Intravenous paracetamol, commonly used for fever and pain, can rarely cause severe hypotension and cardiac arrest. This case highlights a critical adverse event associated with IV acetaminophen administration.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Patient Safety

Background:

  • Paracetamol (acetaminophen) is a widely used antipyretic and analgesic medication.
  • Intravenous (IV) paracetamol is increasingly utilized in hospitals for pain and fever management.
  • Adverse reactions to IV paracetamol are generally rare, with common events including hypotension and hypersensitivity.

Observation:

  • A case report detailing severe hypotension and cardiac arrest in a patient receiving IV paracetamol infusion.
  • This event occurred despite paracetamol's typical safety profile.

Findings:

  • The presented case identifies a rare but severe adverse event linked to IV paracetamol administration.
  • Severe hypotension and subsequent cardiac arrest were observed during the infusion.

Implications:

  • Highlights the importance of vigilance for rare adverse events even with common medications.
  • Suggests the need for careful monitoring during IV paracetamol infusions, especially in vulnerable patients.
  • Informs clinical practice regarding the potential risks associated with intravenous acetaminophen.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
434
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.1K